Cooper Companies (COO) Outperforms Cardinal Health (CAH) in Key Metrics
Table of Contents
- Cooper Companies (COO) Outperforms Cardinal Health (CAH) in Key Metrics
- Profitability Analysis: Cooper Companies Shows Stronger Returns
- Analyst ratings and Price Targets: Higher Upside for Cooper Companies
- Volatility and Risk Assessment
- Earnings and Valuation Metrics
- Institutional and Insider Ownership
- Comparative Table: Cooper Companies vs. Cardinal Health
- About Cooper Companies
- About cardinal Health
- Understanding the Medical Device and Healthcare Industry
In a head-to-head comparison of two large-cap medical companies, Cooper Companies (NASDAQ:COO) emerges as the stronger buisness compared to Cardinal Health (NYSE:CAH). The analysis, focusing on dividends, earnings, analyst recommendations, institutional ownership, risk, profitability, and valuation, reveals Cooper Companies’ dominance in several key areas.But is it the right stock for your portfolio?
Profitability Analysis: Cooper Companies Shows Stronger Returns
Cooper Companies demonstrates superior profitability compared to Cardinal Health. As of June 2024, Cooper Companies boasts a net margin of 10.39%, considerably higher than Cardinal Health’s 0.70%. Furthermore,Cooper Companies exhibits a return on equity of 9.60% versus Cardinal Health’s -68.84%. In terms of asset utilization,Cooper Companies also leads with a return on assets of 6.35%, while Cardinal Health stands at 4.21%.
Analyst ratings and Price Targets: Higher Upside for Cooper Companies
Recent analyst ratings compiled by MarketBeat indicate a positive outlook for both Cooper Companies and Cardinal Health. Cooper Companies currently holds a rating score of 2.73, with 8 buy ratings and 3 hold ratings. Cardinal Health has a slightly higher rating score of 2.79, supported by 11 buy ratings and 3 hold ratings. Though, the consensus price target suggests a greater potential upside for Cooper Companies. The consensus price target for Cooper Companies is $99.70, signaling a potential upside of 43.52%. Conversely, Cardinal Health’s consensus price target of $157.43 indicates a potential downside of 3.47%.
Volatility and Risk Assessment
Cooper Companies exhibits a beta of 0.98,indicating that its share price is 2% less volatile than the S&P 500. Cardinal Health has a beta of 0.66, making its share price 34% less volatile than the S&P 500. This suggests that Cardinal Health may offer a more stable investment option in terms of price fluctuations.
Earnings and Valuation Metrics
Cardinal Health demonstrates higher gross revenue and earnings compared to Cooper Companies. cardinal Health’s gross revenue stands at $226.83 billion,dwarfing Cooper Companies’ $3.90 billion. Similarly, Cardinal Health’s net income is $852.00 million, surpassing Cooper companies’ $392.30 million. Cardinal Health also has higher earnings per share at $6.41 compared to Cooper Companies’ $2.06. The price-to-earnings ratio indicates that Cardinal Health is currently more affordable, trading at 25.44 compared to Cooper Companies’ 33.72.
Did you Know? Institutional investors hold a significantly larger stake in Cardinal Health (87.2%) compared to Cooper Companies (24.4%), suggesting strong confidence from major investment firms.
Institutional and Insider Ownership
Institutional ownership is significantly higher in Cardinal health, with 87.2% of shares held by institutional investors,compared to 24.4% for Cooper Companies. Insider ownership is relatively low for both companies, with 2.0% for cooper Companies and 0.1% for Cardinal Health. Strong institutional ownership frequently enough signals confidence in a stock’s long-term performance [[1]].
Comparative Table: Cooper Companies vs. Cardinal Health
Here’s a summary of key metrics comparing Cooper Companies and Cardinal Health:
| cooper Companies | Cardinal Health | |
| Net Margins | 10.39% | 0.70% |
| Return on Equity | 9.60% | -68.84% |
| Return on Assets | 6.35% | 4.21% |
| Rating Score | 2.73 | 2.79 |
| Consensus Price Target | $99.70 (+43.52%) | $157.43 (-3.47%) |
| Beta | 0.98 | 0.66 |
| Gross Revenue | $3.90 billion | $226.83 billion |
| Price/Earnings Ratio | 33.72 | 25.44 |
| Institutional Ownership | 24.4% | 87.2% |
Pro Tip: When evaluating companies, consider both growth potential and stability. Cooper Companies offers higher potential upside, while Cardinal Health provides more stability with lower volatility.
while Cardinal Health demonstrates higher revenue and a lower price-to-earnings ratio, Cooper Companies excels in profitability, analyst recommendations (based on potential upside), and several other key factors. Cooper Companies appears to be the stronger business based on this extensive comparison, beating Cardinal Health on 8 of the 14 factors.
Which of these factors is most significant to you as an investor? How do you weigh growth potential versus stability when making investment decisions?
About Cooper Companies
The Cooper Companies, Inc. (NASDAQ:COO) focuses on contact lenses and women’s health.Its CooperVision segment offers a range of lenses, including those for astigmatism and myopia control [[2]]. The CooperSurgical segment provides fertility products, medical devices, and contraception. The company distributes its products globally to eye care professionals, hospitals, and clinics. Cooper Companies was founded in 1958 and is headquartered in San Ramon, California.
About cardinal Health
Cardinal Health, Inc. (NYSE:CAH) operates as a healthcare services and products company, providing solutions for hospitals, pharmacies, and other healthcare providers. The company’s Pharmaceutical segment distributes branded and generic pharmaceuticals. The Medical segment manufactures and distributes medical, surgical, and laboratory products. Cardinal Health was incorporated in 1979 and is headquartered in Dublin, Ohio.
Understanding the Medical Device and Healthcare Industry
The medical device and healthcare industry is characterized by constant innovation,regulatory oversight,and evolving patient needs. Companies in this sector must navigate complex supply chains, maintain high standards of quality, and adapt to changing market dynamics. Factors such as aging populations, technological advancements, and healthcare reforms drive growth and create opportunities for companies like Cooper Companies and Cardinal Health.
Past Trends in Healthcare Investments
Historically, investments in healthcare have been considered relatively stable due to the essential nature of medical services. However, the industry is not immune to economic cycles and faces challenges such as rising costs and regulatory pressures. Investors frequently enough look for companies with strong market positions, diversified product portfolios, and a track record of innovation.